Analyst consensus rating
Quoin Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Quoin Pharmaceuticals's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $22.20.
Forecast evidence checked September 7, 2026.
Get free Quoin Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.26
- Average price target
- $22.20
- High price target
- $35.00
- Low price target
- $12.00
- Low target gap
- +65.3%
- Target upside
- +205.8%
- High target gap
- +382.1%
- Target range width
- 316.8%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- September 7, 2026
- Valid through
- September 14, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Quoin Pharmaceuticals?
Quoin Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $22.20.
How far are Quoin Pharmaceuticals's low and high targets from the recorded price?
The low target implies +65.3%, while the high target implies +382.1%.
How many analysts are included in Quoin Pharmaceuticals's consensus?
The verified consensus includes 5 analysts.
How is Quoin Pharmaceuticals's target upside or downside calculated?
The average target of $22.20 is divided by the recorded price of $7.26, then one is subtracted to produce +205.8%. This does not guarantee a future return.
When was Quoin Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-07. The dataset is valid through 2026-09-14.